{"id":"W3034965161","doi":"10.1016/s1470-2045(20)30314-4","title":"COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study","year":2020,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":624,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Foundation Medicine; Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Grifols; PharmaMar; Otsuka Pharmaceutical; Eisai; Institut National de la Santé et de la Recherche Médicale; G1 Therapeutics; Clovis Oncology; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Takeda Pharmaceutical Company; AbbVie; Samsung; Bristol-Myers Squibb; European Respiratory Society; Merck; Spectrum Pharmaceuticals; Bayer; Gilead Sciences; Celgene; Novartis; Exelixis; Sanofi; Roche Italia; GlaxoSmithKline; Pfizer; Incyte; Stanford University; Amgen; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Lung cancer; Internal medicine; Cohort; Cancer registry; Pneumonia; Odds ratio; Population; Cancer; Comorbidity; Stage (stratigraphy)","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1039156265003176,"score_gpt":0.4302376282052922,"score_spread":0.3263220017049746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}